Raman Jay D, Walmsley Konstantin, Goldstein Marc
Department of Urology, Cornell Institute of Reproductive Medicine, New York Presbyterian Hospital, Weill-Cornell University Medical Center, New York, New York, USA.
Urology. 2005 Jun;65(6):1186-9. doi: 10.1016/j.urology.2004.12.057.
To evaluate the inheritance of varicoceles through examination of first-degree relatives of patients with known varicoceles.
A total of 44 patients with a known varicocele had available first-degree relatives (n = 62) examined for the presence of a varicocele between October 1997 and November 2003. An additional cohort of 263 men presenting for vasectomy reversal without a history of subfertility or varicocele was used as the control group. Varicocele grade and the presence of bilateral varicoceles were examined as predictive factors for inheritance.
Of the 62 first-degree relatives of patients with a known varicocele, 35 (56.5%) had a clinically palpable varicocele on physical examination. This was significantly greater than the 18 (6.8%) of 263 men in the control group (P < 0.0001). Of the first-degree relatives, 20 (74%) of 27 brothers, 13 (41%) of 32 fathers, and 2 (67%) of 3 sons had palpable varicoceles. Neither varicocele grade nor bilaterality was predictive of inheritance in these first-degree relatives.
The increase in varicocele prevalence is significant in the first-degree relatives (particularly brothers) of patients with known varicoceles. Given the detrimental effect of varicoceles on spermatogenesis and steroidogenesis, patients should be counseled about this increased risk in male family members.
通过检查已知患有精索静脉曲张患者的一级亲属来评估精索静脉曲张的遗传情况。
在1997年10月至2003年11月期间,共有44名已知患有精索静脉曲张的患者的一级亲属(n = 62)接受了精索静脉曲张检查。另外一组263名前来进行输精管复通术且无生育力低下或精索静脉曲张病史的男性作为对照组。检查精索静脉曲张分级和双侧精索静脉曲张的存在情况作为遗传的预测因素。
在62名已知患有精索静脉曲张患者的一级亲属中,35名(56.5%)在体格检查时可临床触及精索静脉曲张。这显著高于对照组263名男性中的18名(6.8%)(P < 0.0001)。在一级亲属中,27名兄弟中的20名(74%)、32名父亲中的13名(41%)和3名儿子中的2名(67%)可触及精索静脉曲张。在这些一级亲属中,精索静脉曲张分级和双侧性均不能预测遗传情况。
在已知患有精索静脉曲张患者的一级亲属(尤其是兄弟)中,精索静脉曲张患病率的增加是显著的。鉴于精索静脉曲张对精子发生和类固醇生成的有害影响,应向患者告知男性家庭成员中这种增加的风险。